title: [Pharmacokinetics and Intestinal Absorption of Curcumin Chitosan Hydrochloride Coated Liposome in Rats].
abstract: OBJECTIVE
  To investigate the pharmacokinetics and intestinal absorption characteristic of curcumin chitosan hydrochloride coated liposome(CCLP) in SD rats.
  
  
  METHODS
  Blood samples were collected after oral administration. Pharmacokinetic parameters were analyzed by DAS program. Rat single pass intestinal perfusion method was employed to investigate the absorption mechanism.
  
  
  RESULTS
  The AUC0-t, AUC0-∞, t1/2, and Cmax of CCLP were 1. 73-fold, 1. 95-fold, 1. 56-fold and 1. 91-fold of the free drug. The intestinal absorption rate constant (Ka) of CCLP in duodenum, jejunum, ileum and colon were 1. 48, 1. 28, 1. 17 , and 4. 01 times as much as the free drug and the effective permeability(Peff) of CCLP were 1. 58, 1.-33, 1. 30 and 4. 55 times of the free drug, respectively.
  
  
  CONCLUSIONS
  The bioavailability of CCLP in rats is increased remarkably and Ka is increased in various intestinal segments by CCLP, especially in colon, as well as Peff.
authors.forename: Sheng-li
authors.initials: SL
authors.lastname: Wan
authors.forename: Meng
authors.initials: M
authors.lastname: Zhong
authors.forename: Mei
authors.initials: M
authors.lastname: Yang
authors.forename: Xue-yuan
authors.initials: XY
authors.lastname: Hu
authors.forename: Jing-qing
authors.initials: JQ
authors.lastname: Zhang
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D048271:Chitosan / Q000493:pharmacokinetics*; D003106:Colon / Q000378:metabolism; D003474:Curcumin / Q000493:pharmacokinetics*; D007082:Ileum / Q000378:metabolism; D007408:Intestinal Absorption; D007583:Jejunum / Q000378:metabolism; D008081:Liposomes; D010477:Perfusion; D010539:Permeability; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D008081:Liposomes; D048271:Chitosan; D003474:Curcumin